Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/1995
08/30/1995CN1107365A A novel physiologically active substance
08/29/1995US5446189 Diester intermediates for diacid enzyme inhibitor
08/29/1995US5446059 Treating or preventing inflammatory or immunoallergic conditions
08/29/1995US5446052 Dialkylenepiperidino compounds and their enantiomers, process for preparing them and pharmaceutical compositions containing them
08/29/1995US5446035 Stabilize blood calcium and phosphate levels, induce cell differentiation
08/29/1995US5446034 Vitamin D analogues
08/29/1995CA1336810C Synergistic interplay of lymphokines and double stranded rnas
08/26/1995CA2142376A1 Iontophoretic transdermal delivery of deoxyspergualin compounds
08/24/1995WO1995022619A1 B7-1-specific ligands, and their use for the induction of t cell anergy
08/24/1995WO1995022559A1 Immunosuppressive compounds and method of preparing same
08/24/1995WO1995022546A1 Intracellular signalling mediators
08/24/1995WO1995022545A1 2-HETEROARYL-5,11-DIHYDRO-6H-DIPYRIDO[3,2-b:2',3'-e][1,4]DIAZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION
08/24/1995WO1995022538A1 5-substituted derivatives of mycophenolic acid
08/24/1995WO1995022537A2 4-amino derivatives of 5-substituted mycophenolic acid
08/24/1995WO1995022536A1 6-substituted mycophenolic and derivatives with immunosuppressive activity
08/24/1995WO1995022535A1 4-amino derivatives of mycophenolic acid with immunosuppressant activity
08/24/1995WO1995022534A1 4-amino 6-substituted mycophenolic acid and derivatives with immunosuppressive activity
08/24/1995WO1995022520A1 Substituted biphenyl derivatives as phosphodiesterase inhibitors
08/24/1995WO1995022350A1 Composition and method for preventing and treating inflammation with immunoglobulin a
08/24/1995WO1995019435A3 T cell antigen receptor v region proteins and methods of preparation thereof
08/24/1995DE4421159C1 Use of ferric oxide for treating immune deficiency
08/24/1995DE19505287A1 Zusammensetzung und Verfahren zur Prävention und Behandlung von Entzündungen mit Immunglobulin A A composition and method for the prevention and treatment of inflammation with immunoglobulin A
08/24/1995CA2183680A1 B7-1-specific ligands, and their use for the induction of t cell anergy
08/24/1995CA2183571A1 2-heteroaryl-5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection
08/24/1995CA2183566A1 Composition and method for preventing and treating inflammation with immunoglobulin a
08/24/1995CA2183562A1 Intracellular signalling mediators
08/24/1995CA2183533A1 6-substituted mycophenolic acid and derivatives
08/24/1995CA2183532A1 4-amino 6-substituted mycophenolic acid and derivatives
08/24/1995CA2183531A1 4-amino derivatives of 5-substituted mycophenolic acid
08/24/1995CA2183530A1 5-substituted derivatives of mycophenolic acid
08/24/1995CA2183529A1 4-amino derivatives of mycophenolic acid
08/24/1995CA2183157A1 Immunosuppressive compounds and method of preparing same
08/24/1995CA2182792A1 Substituted biphenyl derivatives as phosphodiesterase inhibitors
08/23/1995EP0668075A2 Non-peptide tachykinin receptor antagonists
08/23/1995EP0667908A1 Soluble t-cell receptor alpha chain and derivatives used as prophylactic and therapeutic agents for autoimmune diseases
08/23/1995EP0667904A1 Suppressor and progenitor cells
08/23/1995EP0667902A1 Cdr grafted humanised chimeric t-cell antibodies
08/23/1995EP0667901A1 Novel cytokine
08/23/1995EP0667870A1 COMPOSITIONS AND METHODS FOR MODIFYING THE REGULATORY ACTIVITY OF TGF-$g(b)
08/23/1995EP0667857A1 Indolylcarbamates as anti-inflammatory agents
08/23/1995EP0667856A1 Novel vitamin d analogues
08/23/1995EP0667855A1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis
08/23/1995EP0667792A1 Specific tolerance in transplantation
08/23/1995EP0667789A1 Restoration of immunocompetency to t helper cells in hiv infected patients
08/23/1995EP0667788A1 Allergenic extracts
08/23/1995EP0667787A1 Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines
08/23/1995EP0667770A1 Inhibition of tnf production.
08/23/1995CN1107149A 哌嗪衍生物 Piperazine derivatives
08/22/1995US5444072 Useful in treatment of autoimmune disorders, psoriasis, inflammatory diseases, rheumatoid arthritis
08/22/1995US5444063 95% free of corresponding beta-L enantiomer; oral or parenteral administeration
08/22/1995US5444050 Binding of E-selectin or P-selectin to sialyl Lewisx or sialyl-Lewisa
08/22/1995US5443839 Liposomes containing scutellaria extracts
08/22/1995US5443833 Pharmaceutical compositions
08/22/1995CA1336773C Therapeutic dibenzo-piperazino-azepine derivatives
08/17/1995WO1995021926A1 Inducing tolerance with tolerogenic fusion proteins
08/17/1995WO1995021915A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells
08/17/1995WO1995021819A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
08/17/1995WO1995021625A1 Prolactin as a vaccine adjuvant
08/17/1995WO1995021610A1 Use of derivatives of 2,4-bisubstituted phenols as 5-lipoxigenase inhibitors
08/17/1995WO1995007994A3 Recombinant alphavirus vectors
08/17/1995CA2183260A1 Prolactin as a vaccine adjuvant
08/17/1995CA2183066A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells
08/17/1995CA2182977A1 Inducing tolerance with tolerogenic fusion proteins
08/17/1995CA2182734A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
08/16/1995EP0666917A1 M. paratuberculosis promoter and use thereof in immunogenic sequence expression
08/16/1995EP0666914A1 Novel p-selectin ligand protein
08/16/1995EP0666869A1 Peptides tolerizing t-cells and compositions thereof
08/16/1995EP0666861A1 Rapamycin arylcarbonyl and alkoxycarbonyl carbamates as immunosuppressive and antifungal agents
08/16/1995EP0666856A1 4-arylmethyloxymethyl piperidines as tachykinin antagonists
08/16/1995EP0666849A1 Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis
08/16/1995EP0666760A1 VACCINE COMPRISING PART OF CONSTANT REGION OF IgE FOR TREATMENT OF IgE-MEDIATED ALLERGIC REACTIONS
08/16/1995EP0666758A1 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
08/16/1995EP0666757A1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins
08/16/1995EP0666755A1 Inhibitiion of retrovirus infection
08/16/1995EP0666749A1 ENANTIOMERICALLY PURE beta-D-DIOXOLANE NUCLEOSIDES WITH SELECTIVE ANTI-HEPATITIS B VIRUS ACTIVITY
08/16/1995EP0666740A1 Thiol compounds for strengthening the immune system and immune reactions
08/16/1995EP0371999B1 Nucleic acid and methods for the synthesis of novel fusion polypeptides with a phospholipid anchor domain
08/16/1995EP0335901B1 Pentigetide for treating non-IgE-mediated inflammatory diseases
08/16/1995CN1106980A Anti-aids immunomodulator complex
08/16/1995CN1106801A Isoquinolines
08/15/1995US5441977 Immunosuppressive agent; for treating transplant rejection
08/15/1995US5441976 Immunostimulants
08/15/1995US5441958 Allergic conjunctivitis
08/15/1995US5441953 4- amino derivatives of mycophenolic acid
08/15/1995US5441932 Antiallergens, antiinflammatory agents
08/15/1995CA1336683C Diagnosis and treatment of double-stranded rna deficiency states
08/15/1995CA1336680C Method and compositions for the treatment and prevention of septic shock
08/10/1995WO1995021251A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions
08/10/1995WO1995021180A1 Substituted lactose derivatives as cell adhesion inhibitors
08/10/1995WO1995021164A1 Intermediate and process for making
08/10/1995WO1995020978A1 Use of anti-tnf antibodies as drugs in treating diseases involving elevated interleukin-6 serum levels
08/10/1995WO1995020965A1 Hiv protease inhibitors and intermediates
08/10/1995WO1995020962A1 Protease inhibitors
08/10/1995CA2182723A1 The use of anti-tnf antibodies as drugs for the treatment of disorders with an elevated serum level of interleukin-6
08/10/1995CA2182685A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions
08/10/1995CA2182192A1 Protease inhibitors
08/10/1995CA2182090A1 Hiv protease inhibitors and intermediates
08/10/1995CA2182007A1 Substituted lactose derivatives as cell adhesion inhibitors
08/10/1995CA2180860A1 Intermediate and process for making
08/09/1995EP0666250A1 Derivatives of N-(3-aminopropyl)-N-phenyl-5,6,7,8-tetrahydronaphthalene-2-carboxamide having neuroprotective and anti-ischemic properties, their preparation and their use, in therapy
1 ... 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 ... 1172